The FDA has recently granted 510(k) clearance to Philips for a range of its devices to be used to manage COVID-19 patients in the U.S. The approved products include the Affiniti series, EPIQ series, Lumify, CX50, and Sparq system. These ultrasound devices are used to monitor and manage patients suffering from COVID-19 complications. This range
Philips Granted FDA Clearance for Ultrasound Devices to Manage COVID-19 Complications
